These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9462611)

  • 1. Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty.
    Hamon M; Amant C; Bauters C; Richard F; Helbecque N; Passard F; McFadden EP; Lablanche JM; Bertrand ME; Amouyel P
    Am J Cardiol; 1998 Jan; 81(1):79-81. PubMed ID: 9462611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.
    Wijpkema JS; van Haelst PL; Monraats PS; Bruinenberg M; Zwinderman AH; Zijlstra F; van der Steege G; de Winter RJ; Doevendans PA; Waltenberger J; Jukema JW; Tio RA
    Pharmacogenet Genomics; 2006 May; 16(5):331-7. PubMed ID: 16609364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention.
    Toyofyuku M; Imazu M; Sumii K; Yamamoto H; Hayashi Y; Hiyama K; Kohno N
    Atherosclerosis; 2002 Feb; 160(2):339-44. PubMed ID: 11849656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty.
    van Bockxmeer FM; Mamotte CD; Gibbons FA; Burke V; Taylor RR
    Circulation; 1995 Oct; 92(8):2066-71. PubMed ID: 7554183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.
    Samani NJ; Martin DS; Brack M; Cullen J; Chauhan A; Lodwick D; Harley A; Swales JD; de Bono DP; Gershlick AH
    Lancet; 1995 Apr; 345(8956):1013-6. PubMed ID: 7723497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
    Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
    Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty.
    Hamon M; Bauters C; Amant C; McFadden EP; Helbecque N; Lablanche JM; Bertrand ME; Amouyel P
    Circulation; 1995 Aug; 92(3):296-9. PubMed ID: 7634441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting.
    Gürlek A; Güleç S; Karabulut H; Bokesoy I; Tutar E; Pamir G; Alpman A; Toydemir R; Aras O; Oral D
    J Cardiovasc Risk; 2000 Dec; 7(6):403-7. PubMed ID: 11155292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [I/D polymorphism of the ACE gene and A1166C of the AT1R gene as risk factors for restenosis after coronary angioplasty].
    Gensini F; Battaglini B; Fatini C; Guazzelli R; Falai M; Chioccioli M; Simonetti I; Comeglio M; Giglioli C; Martinucci P; Gensini GF
    Minerva Cardioangiol; 1999 Dec; 47(12):516. PubMed ID: 10670180
    [No Abstract]   [Full Text] [Related]  

  • 12. ACE gene polymorphism and coronary restenosis.
    Bauters C; Amouyel P; Bertrand ME
    Semin Interv Cardiol; 1999 Sep; 4(3):145-9. PubMed ID: 10545620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty.
    Hamon M; Amant C; Bauters C; Lablanche JM; Bertrand M; Amouyel P
    Am J Cardiol; 1996 Sep; 78(6):679-81. PubMed ID: 8831406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
    Völzke H; Hertwig S; Rettig R; Motz W
    Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis.
    Bauters C; Amouyel P
    Eur Heart J; 1998 Sep; 19 Suppl J():J24-9. PubMed ID: 9796837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
    Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
    Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphism in coronary disease and malignant ventricular arrhythmias.
    Anvari A; Türel Z; Schmidt A; Yilmaz N; Mayer G; Huber K; Schuster E; Gottsauner-Wolf M
    Cardiovasc Res; 1999 Sep; 43(4):879-83. PubMed ID: 10615414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease.
    Alvarez R; Reguero JR; Batalla A; Iglesias-Cubero G; Cortina A; Alvarez V; Coto E
    Cardiovasc Res; 1998 Nov; 40(2):375-9. PubMed ID: 9893731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E polymorphism does not predict risk of restenosis after coronary angioplasty.
    Samani NJ; Martin DS; Brack M; Cullen J; Wallis R; Lodwick D; Chauhan A; Harley A; Thompson JR; Gershlick AH; de Bono DP
    Atherosclerosis; 1996 Sep; 125(2):209-16. PubMed ID: 8842352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin I converting enzyme gene polymorphism and coronary heart disease.
    Cambien F; Evans A
    Eur Heart J; 1995 Nov; 16 Suppl K():13-22. PubMed ID: 8869131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.